Related Experiment Video
Updated: Oct 22, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
[Screening for Alzheimer's disease by assessing memory impairment]
Michèle Chazot-Balcon1, Jean-Pierre Bouchard2
1Services de neurologie et de neurochirurgie, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges cedex, France.
Memory complaints are common with aging, but distinguishing them from actual memory pathology is crucial. Early detection of pre-dementia Alzheimer's disease is vital for potential future treatments.
Area of Science:
- Gerontology
- Neurology
- Cognitive Science
Background:
- Memory complaints are a frequent concern in aging populations.
- Differentiating between subjective memory complaints and objective memory pathology is clinically significant.
- Alzheimer's disease is currently diagnosed at the dementia stage, often years after initial pathological changes.
Purpose of the Study:
- To highlight the importance of identifying the pre-dementia phase of Alzheimer's disease.
- To underscore the clinical challenge in distinguishing normal age-related memory decline from early pathological processes.
- To emphasize the growing interest in early detection for potential therapeutic interventions.
Main Methods:
- This study is a review and conceptual analysis of existing literature.
- It synthesizes information on age-related memory changes and Alzheimer's disease progression.
- It discusses the diagnostic criteria and challenges in the pre-dementia phase.
Main Results:
- Subjective memory complaints are common but do not always indicate underlying pathology.
- A significant gap exists between the onset of Alzheimer's disease pathology and clinical diagnosis of dementia.
- The pre-dementia phase offers a critical window for early intervention.
Conclusions:
- Distinguishing memory complaints from pathology is essential for accurate diagnosis and management.
- Focusing on the pre-dementia phase of Alzheimer's disease is crucial for advancing treatment strategies.
- Early detection of cognitive decline holds promise for mitigating the impact of dementia.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

